{"database": "lobbying", "table": "lobbying_activities", "rows": [[828890, "df2be76a-ebde-4ad5-8126-b9dcb7389619", "Q3", "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", 3457, "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", 2009, "third_quarter", "PHA", "Meeting with FDA relating to removal of unapproved products, opportunities for future collaboration; Risk Evaluation and Mitigation Strategies.  Meeting with FDA regarding design and use of NDC number.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", null, 250000, 0, 0, "2009-10-15T12:33:24-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["828890"], "units": {}, "query_ms": 0.2943640574812889, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}